Manulife-Loblaw deal to deliver specialty drugs sparks access, competition concerns
- Manulife Financial Corp has announced that its coverage of certain prescription drugs will only apply at Loblaw Cos. Ltd. pharmacies, raising concerns about competition and patient access to medication.
- This move is part of a preferred pharmacy network arrangement, which is growing in Canada, where insurers exercise market power in the pharmacy sector.
- Some experts argue that the arrangement is beneficial as it forces pharmacies to compete, while others worry about the negative implications for competition and patient access.
26 Articles
26 Articles
Manulife says coverage of some specialty drugs will only apply at Loblaw-owned pharmacies
Canadian insurance company Manulife announced that its coverage of certain specialty prescription drugs will only apply at Loblaw-owned pharmacies, a deal that pharmacare policy experts say raises concerns about competition and patient access to much-needed medication.
Manulife-Loblaw deal to deliver specialty drugs sparks access, competition concerns
Some pharmacare policy experts are raising concerns about competition and patient access to much-needed medication after Manulife Financial Corp. announced its coverage of certain prescription drugs will only apply at Loblaw Cos. Ltd. pharmacies.
Manulife-Loblaw deal to deliver specialty drugs sparks access, competition concerns
Some pharmacare policy experts are raising concerns about competition and patient access to much-needed medication after Manulife Financial Corp. announced its coverage of certain prescription drugs will only apply at Loblaw Cos. Ltd. pharmacies. The new arrangement, details of which were shared wit...
Manulife-Loblaw deal to deliver specialty drugs sparks access, competition concerns
Some pharmacare policy experts are raising concerns about competition and patient access to much-needed medication after Manulife Financial Corp. announced its coverage of certain prescription drugs will only apply at Loblaw Cos. Ltd. pharmacies.
Coverage Details
Bias Distribution
- 65% of the sources lean Left
To view factuality data please Upgrade to Premium